Dr. Zerez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
888 S King St
Honolulu, HI 96813Phone+1 808-522-4359Fax+1 808-522-4277
Education & Training
St Mary Medical CenterResidency, Internal Medicine, 1994 - 1996
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Anesthesiology, 1993 - 1994- St Mary Medical CenterInternship, Internal Medicine, 1992 - 1993
David Geffen School of Medicine at UCLAClass of 1992
Certifications & Licensure
CA State Medical License 1993 - Present
HI State Medical License 2000 - 2026
MD State Medical License 1996 - 2001- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2014
Clinical Trials
- The Effect of Pharmaceutical Grade L-glutamine (Endari) on Glycemic Control in Patients With Diabetes Mellitus Type II Start of enrollment: 2019 May 01
Publications & Presentations
PubMed
- 36 citationsIncreased red cell glutamine availability in sickle cell anemia: Demonstration of increased active transport, affinity, and increased glutamate level in intact red cellsYutaka Niihara, Charles R. Zerez, Dean S. Akiyama, Kouichi R. Tanaka
The Journal of Laboratory and Clinical Medicine. 1997-07-01 - 53 citationsDecreased erythrocyte nicotinamide adenine dinucleotide redox potential and abnormal pyridine nucleotide content in sickle cell disease.Charles R. Zerez, Neil A. Lachant, Sandra Lee, Kouichi R. Tanaka
Blood. 1988-02-01 - 97 citationsOral L‐glutamine therapy for sickle cell anemia: I. subjective clinical improvement and favorable change in red cell NAD redox potentialYutaka Niihara, Charles R. Zerez, Dean S. Akiyama, Kouichi R. Tanaka
American Journal of Hematology. 1998-06-01
Grant Support
- NAD And NADP Metabolism In Human Red Cell EnzymopathiesNational Heart, Lung, And Blood Institute1986–1988
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
